Saudi Arabia OTC Artificial Tears Market Sees Steady Growth Amid Rising Eye Health Awareness

Market Snapshot

According to Renub Research Recent Report Saudi Arabia OTC (Over-the-Counter) Artificial Tears Market is projected to reach US$ 79.09 million by 2033, rising from US$ 54.52 million in 2024, at a CAGR of 4.22% between 2025 and 2033. The country’s aging population, rising incidence of dry eye syndrome, prolonged use of digital devices, and increasing awareness of eye health are collectively shaping strong demand for easily accessible, non-prescription eye care solutions.

Artificial tears are lubricating eye drops designed to relieve dryness, irritation, and discomfort caused by insufficient tear production. Available without a prescription, these products are often the first line of defense for mild to moderate eye conditions and are widely accessible in pharmacies, retail outlets, and online platforms. With growing consumer preference for self-care and convenience, OTC artificial tears are becoming an essential segment of Saudi Arabia’s healthcare market.

Understanding the Market

OTC artificial tears mimic the composition of natural tears to moisten and protect the eye surface. They are used to treat conditions like dry eye syndrome, computer vision syndrome, contact lens irritation, and environmental discomfort caused by pollution or air conditioning. The market offers a wide array of formulations, from solutions and gels to sprays and preservative-free options tailored for sensitive users.

The increasing dependence on screens for work, education, and leisure has exacerbated eye strain in Saudi Arabia. Combined with the country’s arid climate, rising pollution levels, and widespread air conditioning use, these factors have significantly contributed to higher rates of ocular dryness. As awareness about preventive eye care spreads, more individuals are turning to artificial tears for quick, affordable, and effective relief.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Key Growth Drivers

1. Rising Prevalence of Dry Eye Conditions

Studies highlight the growing burden of dry eye syndrome (DED) in Saudi Arabia. The 2022 Twaiq Mountain Eye Study found that 16.4% of individuals suffered from severe symptoms, while nearly half of the surveyed population experienced some form of DED. Another study revealed that 39.7% of Saudi health sciences students reported dry eye symptoms linked to digital eye strain. These statistics emphasize the need for accessible treatments, making OTC artificial tears a vital solution for daily relief.

2. Consumer Preference for Non-Prescription Solutions

Saudi consumers increasingly favor non-prescription remedies due to growing health awareness and the convenience of self-care. OTC artificial tears eliminate the need for clinic visits, providing affordable, fast relief for mild to moderate eye discomfort. This preference aligns with a global trend toward proactive wellness management and self-reliance, where individuals seek quick, accessible solutions for minor health concerns.

3. Expansion of Retail and Online Distribution Channels

Saudi Arabia’s Vision 2030 initiative has spurred major investments in retail infrastructure, increasing the availability of eye care products in both urban and rural areas. Pharmacies, supermarkets, and optical stores have expanded significantly, making artificial tears widely accessible. Meanwhile, e-commerce platforms and online pharmacies have revolutionized product availability, offering wider selections, competitive pricing, and detailed product information, further boosting consumer adoption.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Challenges Facing the Market

Regulatory Hurdles

Stringent regulations govern the distribution and certification of eye care products in Saudi Arabia. Compliance with evolving health regulations often requires extensive resources, delaying product launches and creating barriers for both domestic and international manufacturers. These hurdles can restrict product diversity and potentially increase consumer costs, slowing market innovation.

High Competition

The market is highly competitive, with a large number of local and international players vying for consumer attention. Price sensitivity among consumers forces brands to maintain competitive pricing while ensuring product quality and safety. Established global players such as Alcon, Johnson & Johnson, and Novartis have strong brand recognition, making it difficult for smaller firms to gain traction. This intense competition can compress profit margins and limit growth opportunities.

Market Segmentation

By Product Type:

Solution

Ointment

Emulsion

Gel

Spray Solution

Suspensions

By Application:

Dry Eye Syndrome

Allergies

Infections

UV and Blue Light Protection

Contact Lens Moisture Retention

Others

By Distribution Channel:

Drugstores & Supermarkets

Online Pharmacies

Retail Pharmacies

Others

This segmentation reflects how diverse consumer needs are being addressed, from targeted solutions for allergies and infections to products designed for screen-related eye strain and lens wearers.

Key Players in the Market

Leading companies are focusing on product innovation, preservative-free formulations, and strategic partnerships to maintain a competitive edge. Major players include:

AbbVie Inc.

Akorn Inc.

Alcon

Bausch Health Companies Inc.

Johnson & Johnson

Nicox S.A.

Novartis AG

Santen Pharmaceutical Co. Ltd.

Sun Pharmaceutical Industries Ltd.

These firms employ strategies such as expanding retail presence, leveraging e-commerce, and introducing advanced eye drop technologies to strengthen market positioning.

Future Outlook

As Saudi Arabia continues to modernize its healthcare and retail sectors under Vision 2030, the OTC artificial tears market is poised for steady expansion. Growing public awareness of eye health, combined with the country’s demographic shifts and lifestyle changes, will sustain demand for non-prescription solutions.

While regulatory hurdles and competition remain challenges, the market’s long-term outlook is positive. Innovations such as preservative-free products, smart packaging, and biocompatible formulations will appeal to a wider consumer base. With an emphasis on convenience, accessibility, and preventive care, Saudi Arabia’s OTC artificial tears market is set to play an increasingly important role in the Kingdom’s evolving healthcare landscape.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.